Immunotherapy of malignant disease: The use of viable sensitized lymphocytes or transfer factor prepared from sensitized lymphocytes
- 1 February 1974
- Vol. 33 (2) , 394-401
- https://doi.org/10.1002/1097-0142(197402)33:2<394::aid-cncr2820330214>3.0.co;2-p
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- The Wiskott-Aldrich SyndromeJournal of Clinical Investigation, 1972
- Chemotherapy of Melanoma of the Extremities by PerfusionAnnals of Surgery, 1972
- NEW APPROACH TO IMMUNOTHERAPY OF MELANOMAThe Lancet, 1971
- RNA-mediated transfer of tumor immunity —A new model for the immunotherapy of cancerCancer, 1971
- Immunologic Response in Patients with Disseminated CancerAnnals of Surgery, 1968
- Conversion of Non-immune Cells into Antibody-forming Cells by RNANature, 1967
- Clinical Immunologic Study of Malignant DiseaseAnnals of Surgery, 1966
- THE EFFECT OF LYMPHOID CELLS FROM THE LYMPH OF SPECIFICALLY IMMUNISED SHEEP ON THE GROWTH OF PRIMARY SARCOMATA IN RATSThe Lancet, 1966
- PRELIMINARY OBSERVATIONS ON TREATMENT OF ADVANCED CANCER BY INJECTION OF ALLOGENEIC SPLEEN CELLSThe Lancet, 1963
- ANTIBODY FORMATION IN VITROThe Journal of Experimental Medicine, 1961